BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE April 2004 Click on Study Title to View Report April 16, 2004 Butenhoff, J.L., et al., "Characterization of Risk for General Population Exposure to Perfluorooctanoate," Regulatory Toxicology and Pharmacology 39 (2004) 363-380, April 16, 2004
refid# O3Q36R9QGYdjpw724GDyK5RxM1 page
BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE ATTACHMENT TO LETTER OF 1/18/05 Click on Study Title to View Report Multiple Chemicals Page: 1 1.
refid# O1QRdyKQD6e97r0RML9jdEQxj1 page
At*S-/ff Toxicological Summary PFOS Dietary Chronic Pilot Reproductive Study: Mallard Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoropotassium salt, CAS# 2795-39-3 Test Remarks: The test substance is a white powder (3M Lot #217).
refid# OEq9VQGV02V34zZZGQr8OqgmX12 pages
Toxicological Summary PFOS Dietary Acute Northern Bobwhite Study Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, potassium salt, CAS# 2795-39-3 Remarks: The test substance is a white powder (3M lot #217).
refid# MJ0yxNbNneErpOnovq5RbO1a11 pages
A m & -1105 Sponsor: 3M St.
refid# zQvV1N8p3g6E4yE9RYRwyE7dR76 pages
AR226-2006 INTEROFFICE MEMORANDUM Date: From; Dept; Tel No; 14-Mar-1383 10:34om William A.
refid# 6bOw08VVe6rngJLz0pN3DKkR62 pages
AR226-2224 g ?
refid# rB1VxnOrnQBDBNybGeYr3pbXv1 page
AR226-2270 GIST MEETING M arch 5,2002 Dave Watkins, chairperson, called the meeting to order at 9:15 am on March 5,2002.
refid# qa7n30KVd3o7X0MbX78o5pDLj6 pages
AR226-2332 f?
refid# JNyDzwjQpyznr4BDXKedBvpbO2 pages
AR226-2558 Andrew S Hartten 05/31/2001 03:29 PM To: wentworth.william@ epamall.epa.gov cc: Robert L Ritchey/CL/DuPont@ DuPont, Isidores J Zanikos/AE/DuPont@DuPont, Andrea V Malinowski/AE/DuPont@DuPont, Alison A Crane/AE/DuPont@DuPont Subject: Information on W ashington W orks Facility B ill, The following provides answers to your questions in the May 23 memo you sent me, which Is attached.
refid# 4a3pNgnEo9275aBOar3pYD5dN2 pages
Date: January 9, 2006 AR SS.G - 36 70 Final Report Epidemiology, 220-6W-08 Medical Department 3M Company St.
refid# 2qYa1QRxnQ30VkM208z852gaa20 pages
NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 600-331-2838 513-381-2836 FAX: 513-381-6613 DAYTON, OHIO OFFICE SUITE 800 110 NORTH MAIN STREET DAYTON, OHIO 45402-1766 937-228-2838 FAX: 937-228-2816 Robert A.
refid# 3909eYL9VVZYGDVmKgZR80py3 pages
P-1 COMPANY SANITIZED - Does not contain TSCA Confidential Business Information (CBI) DAUUN AZza _ 3730 fi o>2 <> DAIKIN AMERICA, INC. 905 State Docks Road (35601) P.O.
refid# L2eE438p1E0mD54z5OaOOKqX2 pages
gens. too6. ti' fg MZ76- illf-f DuPont Haskell Laboratory for Health and Environmental Sciences Elkton Road, P.O.
refid# o93xzGeerQoQq7kEmEo9ZRLY72 pages
Taft/ Taft Stettinius & Hollister LLP 425 Walnut Street, Suite 1800 /Cincinnati, Ohio 45202-3957 /Tel: 513.381.2838 / Fax: 513.381.0205 / www.taftlaw.com Cincinnati /Columbus /Cleveland /Dayton /Covington /Phoenix Robert A.
refid# GK827me7v325p2g7OBr1Ozx672 pages